We have had a gutful: The need for deprescribing proton pump inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2710|43|1|65-72

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.43, Iss.1, 2018-02, pp. : 65-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

We must be judicious when prescribing proton-pump inhibitors

By Deshpande Amar  

Therapy, Vol. 7, Iss. 5, 2010-09 ,pp. : 543-545

Future Medicine

Access to resources Recommend Favorite

Editorial: proton pump inhibitors in cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 592-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prevalence of co-administration of clopidogrel and proton pump inhibitors

By Shrestha Kajal   Hughes Jeffery David   Lee Ya Ping   Parsons Richard  

Quality in Primary Care, Vol. 19, Iss. 1, 2011-02 ,pp. : 35-42

Radcliffe Press

Access to resources Recommend Favorite

Proton pump inhibitors and hypomagnesemia in patients with arrhythmias

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1525-1526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deprescribing

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 352-356

John Wiley & Sons Inc

Access to resources Recommend Favorite